author-photo

Cynthia X. Ma

Washington University in St. Louis
University of Washington

300

Papers

7487

Citations

Citation Trend

Filter By

Papers (300) Sort By

Journal Conference Others

Intermittent fasting in the prevention and treatment of cancer

2021 CA: A Cancer Journal for Clinicians
Show All
- Source
- Cite
- Save
Citations (1)
Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.

2021 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Breast Cancer, HER2 Mutations, and Overcoming Drug Resistance.

2021 The New England Journal of Medicine
- Ron Bose
- Cynthia X. Ma
Show All
- Source
- Cite
- Save
Citations (0)
A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer.

2021 Clinical Breast Cancer
Show All
- Source
- Cite
- Save
Citations (0)
RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies.

2021 Frontiers in Genetics
Show All
- Source
- Cite
- Save
Citations (9)
Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1.

2021 Cell Reports
Show All
- Source
- Cite
- Save
Citations (2)
Abstract SP012: Convergent evolution of resistance pathways during early stage breast cancer treatment with combination cell cycle (CDK) and endocrine signaling inhibitors

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD2-10: Validation of a predictive model for potential response to neoadjuvant endocrine therapy (NET) in postmenopausal women with clinical stage II or III estrogen receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC): An ALTERNATE trial analysis (Alliance A011106)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients.

2021 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PS2-18: Circulating tumor DNA (ctDNA) mutation (mut) profile in relation to paboclicib (pal) efficacy in hormone receptor positive (HR+) and HER2 negative (HER2-) metastatic breast cancer (MBC)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)